Intensive chemotherapy, intensieve chemotherapie, AML, ALL, Burkitt lymphoma, Burkitt lymfoom, mantle cell lymphoma, mantelcellymfoom, multiple myeloma, multipel myeloom
Conditions
Interventions
On the haematology ward of the hospital, 9 single-bed rooms will be equipped with dynamic light as well as standard light. The design of the study is a randomized controlled trial. Patients will be ra
Sponsors
Erasmus Medical Center
TNO
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient at least 18 yrs old; 2. Admitted to the haematology dept in a private patient room equipped with dynamic light as well as standard light; 3. Written informed consent; 4. Expected length of stay approx 3 weeks with room arrest; 5. Patients requiring intensive chemotherapy, due to AML, ALL, Burkitt lymphoma, mantle cell lymphoma, and multiple myeloma.
Exclusion criteria
Exclusion criteria: 1. Active depression; 2. Visual handicapped due to ocular pathologies like macula degeneration, severe cataract or severe diabetic retinopathy; 3. Sleep apnoe syndrome; 4. Extreme light sensitivity; 5. Insufficient fluency in Dutch language.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Difference in wakefullness during the time presumed sleeping between both groups. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Subjective quality of sleep; 2. Depression; 3. Delirium as diagnosed by a psychiatrist; 4. Clinical parameters (complications, blood pressure, heart rate, temperature, pain score); 5. Duration of hospitalization; 6. Medication with special attention to benzodiazepines, antipsychotics, antidepressants, corticosteroids, and other medication with known psychiatric side effect (such as voriconazole). | — |
Contacts
Public ContactM.E. Heel, de
ErasmusMC HV 217 Postbus 2040
Outcome results
None listed